Frontiers in oncology.

The Cardio-Oncology section of Frontiers in Cardiovascular Medicine is to provide a prime publication platform for this emerging field in medicine. It should speak to clinicians and researchers across the multiple diciplines that contribute to this field, including cardiology, oncology, hematology, radiation oncology, surgery, internal medicine, pediatrics, …See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ...Further, Artificial Intelligence and Machine Learning (ML) techniques are also being interlaced with omics strategies to shed light on these molecular mechanisms and provide insight into the genetic and molecular abnormalities that are at play in oral cancer.ML strategies enhance the opportunities to discover novel predictive models for …Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...

The Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of HPB neoplasia. Even though the molecular machinery triggering and sustaining HPB carcinogenesis and the morphogenetic …The objective of the Skin Cancer section is to expand our understanding of molecular and cellular mechanisms involved in skin cancer progression. Moreover, the section is dedicated to the publication of high-quality clinical, translational research as well as bioinformatics studies in a timely manner. We are especially interested in receiving ...3 days ago · bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.

Dec 21, 2023 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...

See all (603) Learn more about Research Topics. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.The official journal of the International Union of Immunological Societies (IUIS) and the most cited in its field, leading the way for research across basic, translational and clinical immunology.Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.brian jensen. School of Medicine, University of North Carolina at Chapel Hill. Chapel Hill, United States. Associate Editor. Cardio-Oncology. Part of a forward-thinking journal, this section covers the entire emerging interface between …

Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center.

Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health …

These were assessed using the American Society of Clinical Oncology and the American College of Pathologist guidelines, employing immunohistochemical methods (26, 27). sTIL levels, classified as low, intermediate, or high (0-10%, 11-39%, and ≥40%, respectively), were determined based on recommendations from previous research (16, …3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing on advancements in information in cancer biology. Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, ranking among the top journals in the category of oncology.Explore the impact and performance of Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the number of citations, articles, views, …

3 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. The association between objective imaging response and first line immune checkpoint inhibitor (ICI) therapy regimes in advanced melanoma remains …Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ...In 2019, in Italy, 53,000 new cases of breast cancer have been reported, representing the most commonly diagnosed cancer in women: it can be estimated that …If you’re looking for an affordable airline option, Frontier Airlines might be the perfect choice. With their low fares and various routes, it’s no wonder that many travelers choos...Frontiers in Oncology has an h-index of 121.It means 121 articles of this journal have more than 121 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each …Special Issue Information. Dear Colleagues,. Pancreatic adenocarcinoma is an aggressive malignancy associated with poor prognosis and is the fourth most common ...

2 days ago · Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.

Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.Department of Oncology, Infermi’s Hospital, Azienda Unità Sanitaria Locale (AUSL) della Romagna, Faenza, Italy; Around 8–12% of patients with advanced colon rectal cancer (CRC) present with BRAF alterations, in particular V600E mutation, which is associated with right-side, poorly differentiated and mucinous type tumors.Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.Abbreviation: FRONT ONCOL. ISSN: 2234-943X. eISSN: 2234-943X. Category / Quartile: ONCOLOGY - SCIE (Q2) WoS Core Citation Indexes: SCIE - Science Citation Index …May 10, 2024 · This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment. Advances in Clinical Sarcoma Research: Quality of Life in Sarcoma Patients. Alexander Klein. Dimosthenis Andreou. Dorit Di Gioia. 1,876 views. 2 articles. Advances understanding of new diagnostic and therapeutic strategies of surgical relevance that demonstrably impact cancer patient outcomes.A multidisciplinary team (MDT) in oncology is defined as the cooperation between different specialized professionals involved in cancer care with the overarching goal of improving treatment efficiency and patient care. Head and neck cancer (HNC) involves multiple and biologically distinct diseases that require different therapeutic approaches.

The International Cardio-Oncology Society registry shows 21 countries with national cardio-oncology programs, and 81% of centers are in upper-middle to high-income countries . A study of oncologists in the central US showed 67.5% practiced in exclusively urban locations, 11.3% in exclusively rural locations, and 21.1% in both rural and urban …

The Gastrointestinal Cancers: Colorectal Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of colorectal neoplasia. Even though the molecular machinery triggering and sustaining colorectal carcinogenesis and the morphogenetic pathways leading ...

Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use innovative ...Flying with Frontier Airlines can be a great way to travel affordably, and their website, flyfrontier.com, is an essential tool for booking flights, managing reservations, and acce...These were assessed using the American Society of Clinical Oncology and the American College of Pathologist guidelines, employing immunohistochemical methods (26, 27). sTIL levels, classified as low, intermediate, or high (0-10%, 11-39%, and ≥40%, respectively), were determined based on recommendations from previous research (16, …Choosing the right location for your frontier business can make or break its success. A frontier location near you not only provides convenience, but it also offers the opportunity...Table 1: Frontiers' APCs are structured in four categories, depending on the journal's maturity and the level of research funding and/or open access funding available in various research communities. They also support article types with lower prices or articles that are free of charge. Frontiers' APCs are charged in US$.Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.Submissions that are surgical in nature are not in scope for this section and should be submitted to the Surgical Oncology Section of Frontiers in Oncology. Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and …This Frontiers in Oncology Special Issue marks the 1st edition of a collection of selected articles published in the journal over the course of the previous calendar year, highlighting ongoing research and advances being carried out in the different disciplines of cancer research.A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients.Integrative oncology becomes a critical component of evidence-informed, patient-centered cancer care, helping patients and their families navigate the ...

Immunobiology and Immunotherapeutics in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Shyam Patel. Anna Aureli. Alessandro Isidori. Claudio Cerchione. 2,536 views. 2 articles. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and ...Description. Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring all relevant Specialties in Oncology together on a single platform. Frontiers in Oncology is composed of the following Specialty Sections: Frontiers in Cancer ...Further, Artificial Intelligence and Machine Learning (ML) techniques are also being interlaced with omics strategies to shed light on these molecular mechanisms and provide insight into the genetic and molecular abnormalities that are at play in oral cancer.ML strategies enhance the opportunities to discover novel predictive models for …If you’re looking for an affordable airline option, Frontier Airlines might be the perfect choice. With their low fares and various routes, it’s no wonder that many travelers choos...Instagram:https://instagram. plane tickets to mazatlanlucy dreamingabc 6 philadelphiareal money blackjack online Frontier Airlines is a popular low-cost carrier that offers budget-friendly travel options for those looking to explore new destinations without breaking the bank. With a focus on ... airfare to balifree dominoes game online Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.The objective of the Skin Cancer section is to expand our understanding of molecular and cellular mechanisms involved in skin cancer progression. Moreover, the section is dedicated to the publication of high-quality clinical, translational research as well as bioinformatics studies in a timely manner. We are especially interested in receiving ... walgreens digital coupons Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.The immunogenicity of cancer cells is a new determinant of anti-cancer immunotherapy. In addition to the development of dendritic cell-based vaccines, immune checkpoint inhibitors and adoptive T cell transfer, researchers have begun to pay more attention on the immunobiology of dead cancer cells and their correlation with the success of cancer ...Aims and scope. Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis ...